COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02446652
Recruitment Status : Unknown
Verified May 2015 by Dr. Lucely Cetina Pérez, National Institute of Cancerología.
Recruitment status was:  Not yet recruiting
First Posted : May 18, 2015
Last Update Posted : May 18, 2015
Psicofarma S.A. de C.V.
Information provided by (Responsible Party):
Dr. Lucely Cetina Pérez, National Institute of Cancerología

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : August 2018
Dueñas-Gonzalez A, Hinojosa García LM. Papel de la quimioterapia en el carcinoma cervicouterino. Rev Inst Nac Cancerol 46: 47-57, 2000.
Lewis MJ. Análisis de la situación del cáncer cervicouterino en América Latina y el Caribe. Washington, D.C. Organización Panamericana de la Salud / Organización Mundial de la Salud (OPS/OMS); 2004:40.